Market intelligence - Page 3

Top ten generic companies 21 September, 2012 GlobalData highlights the top ten generic pharmaceutical companies by...

Identity trust in cyberspace 21 September, 2012 As the industry embraces mobile computing, Mollie Shields-Uehling,...

Take five: significant pharma industry deals in Q2/Q3 21 September, 2012 With insight from GlobalData, we take a look at five of the recent deals...

Pharma deals on the rise 02 March, 2012 The quantity of mergers and acquisitions is falling in the pharmaceutical...

Top ten generic pharma 02 March, 2012 The impending patent cliff will mean losses for Big Pharma, but gains...

Pharma’s emerging focus 02 March, 2012 As countries begin to recover from the effects of the recession,...

Healthcare opportunities abound 02 March, 2012 How consumers look after their health has many implications for...

Buying niche and new businesses 01 February, 2012 The pharmaceutical industry’s most significant mergers and acquisitions...

Sustainable growth: pharma goes green 01 February, 2012 World Pharmaceutical Frontiers examines the key findings from the latest...

Top ten global pharma 01 February, 2012 Dr Vishal Agrawal, project manager, and Sunehli Jamwal, analyst,...